ArticlePediatric cardiology2026
Impact of PDA Closure Methodology on Peri-procedural Opioid Utilization in Preterm Neonates, a Cross-Sectional Review in a Tertiary Pediatric Healthcare System.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Optimal timing for transcatheter device occlusion of a hemodynamically significant patent ductus arteriosus in preterm infants: evidence, uncertainty, and future directions.Journal of perinatology : official journal of the California Perinatal Association · 2026Review
- Complications of Interventional Versus Surgical Closure of Patent Ductus Arteriosus in Very Preterm Infants-A Retrospective Analysis.Journal of cardiovascular development and disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To study the association between technique for definitive closure of PDA and peri-procedural opioid utilization in preterm neonates. A retrospective cohort study comprising all premature neonates and infants with a PDA who underwent surgical ligation (SL) between February 2020 and December 2022 or transcatheter PDA closure (TCPC) between August 2020 and February 2023. Intra-procedural and post-procedural opioid use was systematically quantified and compared between the two groups before and after 1:1 propensity score matching. We hypothesized that preterm neonates and infants undergoing TCPC will have an overall reduction in peri-procedural opioid exposure compared to those undergoing SL. The study included 52 preterm infants in the SL group and 74 in the TCPC group. After propensity score matching, infants undergoing TCPC received significantly lower intra-procedural (4.33 vs 5.99 µg/kg, P = 0.037) and post-procedural (0.09 vs 0.32 mg/kg, P < 0.001) opioids. A significantly lower proportion of infants undergoing TCPC were exposed to post-procedural opioids (60.8% vs 92.3%, P = < 0.001). In a multivariable logistic regression model, surgical ligation was associated with sevenfold higher odds of post-procedural opioid exposure compared to TCPC (OR 7.2, 95% CI of 2.1-24.2, P = 0.001). Transcatheter PDA device closure is associated with significantly lower neonatal opioid exposure.
Indexed as
Identifiers
40192760What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.